During the forecast period, the pancreatic stone protein testing market is expected to grow at a rapid 1.8% CAGR. The pancreatic stone protein testing market is currently valued at US$ 3 billion in 2022, with a projected value of US$ 3.59 billion by 2032. Different pancreatic secretory proteins have been identified in the last decade. That is …
Category Archives: Healthcare Trends
Peptide Receptor Radionuclide Therapy (PRRT) Market Report: Unveiling a 7.2% CAGR Ascent Toward US$ 1,106.50 Million by 2032 | FMI
During the forecast period, the peptide receptor radionuclide therapy (prrt) market is expected to grow at a strong CAGR of 7.2%. The market is currently worth US$ 552.08 million in 2022 and is expected to grow by US$ 1,106.50 million by 2032. This Peptide Receptor Radionuclide Therapy market study offers a comprehensive analysis of the business models, key …
Next Generation Infusion Pump Sector’s Robust Growth at 4.8% CAGR, Aiming for US$ 8509 Million by 2032 | FMI Analysis
The global next generation infusion pump market is expected to reach US$ 5059.7 million in 2022 and US$ 8509 million by 2032, with a CAGR of 4.8% during the forecast period (2022-2032). Next Generation Infusion Pumps are a combination of intuitive user interface, simplicity, state of the art information technology. They are inclined with an advanced pumping …
Insightful Analysis: New Born Eye Imaging Systems Market to Grow at 5.7% CAGR, Reaching US$ 374.3 Million by 2032 | FMI
It is anticipated that the new born eye imaging systems market will reach US$ 374.3 million by 2032, up from US$ 202.7 million in 2022, growing at a CAGR of 5.7% during the projection period. Eye is the most complex sensory organ of the body, eye is like a camera of higher resolution for capturing the image, …
A Comprehensive Study: Myelodysplastic Syndrome Treatment Market’s Path to US$ 5,614.1 Million by 2032 | FMI
The global myelodysplastic syndrome treatment market is poised to register a 5.9% CAGR, capturing a revenue share of US$ 2,990.8 million in 2022, to reach US$ 5,614.1 million by 2032. Myelodysplastic syndromes (MDS) are conditions that can occur when the blood-forming cells in the bone marrow are damaged. This damage leads to low numbers of one or more type of …
Hybrid Grafts Market Expected to Grow at 5.20% CAGR, Reaching US$ 858.7 Million by 2032 | FMI Insights
The global hybrid grafts market size is expected to reach US$ 517.3 million by the end of 2022, with a CAGR of 5.20% between 2022 and 2032. The market is anticipated to be worth US$ 858.7 million by 2032. Because of the growing risk of cardiovascular disease and the expanding adoption of unhealthy lifestyles that contribute to …
Motorized Prosthesis Market on Track to Attain US$ 139.4 Million by 2032, with a 14.4% CAGR | FMI
The global motorized prosthesis market size is expected to reach US$ 139.4 Million in 2032. The motorized prosthesis market is growing rapidly. As per FMI Analysts, the global motorized prosthesis market is estimated to be valued at US$ 31.9 Million in 2022 and is projected to increase at a CAGR of 14.4% in the forecast period from 2022 to 2032. Motorized prosthesis is an artificial medical …
Stretch Marks Treatment Market: Unveiling Skin’s Potential, Poised to Surpass US$ 5.82 Billion by 2033
During the forecast period, the Stretch Marks Treatment Market is expected to grow at a steady CAGR of 8.81%. The market is expected to generate US$ 2.5 billion in revenue in 2023, with a value of US$ 5.82 billion by 2033. More people turning obese, therefore, advanced treatment options and higher per capita income are pushing people …
Skull Clamp Market: Fortifying Cranial Care, Set to Secure US$ 5.07 Billion Valuation by 2033
The Skull Clamp Market is expected to be valued at US$ 2.14 billion in 2023, rising to US$ 5.07 billion by 2033. During the forecast period, the market will grow at a CAGR of 9%. How Healthcare Manufacturers Are Growing the Global Market? Healthcare manufacturers are constantly looking for ways to improve and grow the market by developing new …
Autoimmune Disease Testing Market: Unlocking Opportunities on the Path to US$15.75 Billion by 2033
The global market for Autoimmune Disease Testing is expected to grow from US$ 6.07 billion in 2023 to $15.75 billion by 2033. According to FMI, global demand for autoimmune disease testing could grow at a 10% CAGR from 2023 to 2033. The rising incidence of autoimmune disorders, such as rheumatoid arthritis, lupus, and multiple sclerosis, is fueling …